380 related articles for article (PubMed ID: 34576262)
21. QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model.
Kalra J; Warburton C; Fang K; Edwards L; Daynard T; Waterhouse D; Dragowska W; Sutherland BW; Dedhar S; Gelmon K; Bally M
Breast Cancer Res; 2009; 11(3):R25. PubMed ID: 19409087
[TBL] [Abstract][Full Text] [Related]
22. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.
Shrivastava A; Kuzontkoski PM; Groopman JE; Prasad A
Mol Cancer Ther; 2011 Jul; 10(7):1161-72. PubMed ID: 21566064
[TBL] [Abstract][Full Text] [Related]
23. Enhancing therapeutic efficacy in breast cancer: a study on the combined cytotoxic effects of doxorubicin and MPC-3100.
Gökşen Tosun N
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3249-3259. PubMed ID: 37917369
[TBL] [Abstract][Full Text] [Related]
24. L-Canavanine Potentiates Cytotoxicity of Chemotherapeutic Drugs in Human Breast Cancer Cells.
Nurcahyanti AD; Wink M
Anticancer Agents Med Chem; 2017; 17(2):206-211. PubMed ID: 26902604
[TBL] [Abstract][Full Text] [Related]
25. Selective tumor sensitization to taxanes with the mAb-drug conjugate cBR96-doxorubicin.
Wahl AF; Donaldson KL; Mixan BJ; Trail PA; Siegall CB
Int J Cancer; 2001 Aug; 93(4):590-600. PubMed ID: 11477565
[TBL] [Abstract][Full Text] [Related]
26. In vitro sensitivity of human endometrial cancer cell lines to paclitaxel or irinotecan (CPT-11) in combination with other aniticancer drugs.
Hiramatsu HP; Kikuchi Y; Seto H; Nagata I
Anticancer Drugs; 2000 Aug; 11(7):573-8. PubMed ID: 11036961
[TBL] [Abstract][Full Text] [Related]
27. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells.
Prados J; Melguizo C; Rama AR; Ortiz R; Segura A; Boulaiz H; Vélez C; Caba O; Ramos JL; Aránega A
Cancer Chemother Pharmacol; 2010 May; 66(1):69-78. PubMed ID: 19771430
[TBL] [Abstract][Full Text] [Related]
28. Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models.
Patel N; Kommineni N; Surapaneni SK; Kalvala A; Yaun X; Gebeyehu A; Arthur P; Duke LC; York SB; Bagde A; Meckes DG; Singh M
Int J Pharm; 2021 Sep; 607():120943. PubMed ID: 34324983
[TBL] [Abstract][Full Text] [Related]
29. Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment.
Duong HH; Yung LY
Int J Pharm; 2013 Sep; 454(1):486-95. PubMed ID: 23792465
[TBL] [Abstract][Full Text] [Related]
30. Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line.
Bober P; Alexovic M; Talian I; Tomkova Z; Viscorova Z; Benckova M; Andrasina I; Ciccocioppo R; Petrovic D; Adamek M; Kruzliak P; Sabo J
J Cancer Res Clin Oncol; 2017 Jan; 143(1):35-42. PubMed ID: 27620743
[TBL] [Abstract][Full Text] [Related]
31. Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells.
Li F; Miao L; Xue T; Qin H; Mondal S; Thompson PR; Coonrod SA; Liu X; Zhang X
J Exp Clin Cancer Res; 2019 Oct; 38(1):414. PubMed ID: 31601253
[TBL] [Abstract][Full Text] [Related]
32. Curcumin and paclitaxel induce cell death in breast cancer cell lines.
Calaf GM; Ponce-Cusi R; Carrión F
Oncol Rep; 2018 Oct; 40(4):2381-2388. PubMed ID: 30066930
[TBL] [Abstract][Full Text] [Related]
33. Combination paclitaxel and vinorelbine therapy: in vitro cytotoxic interactions and dose-escalation study in breast cancer patients previously exposed to anthracyclines.
Culine S; Roch I; Pinguet F; Romieu G; Bressolle F
Int J Oncol; 1999 May; 14(5):999-1006. PubMed ID: 10200354
[TBL] [Abstract][Full Text] [Related]
34. Synergistic and antagonistic combinations of drugs in human prostate cancer cell lines in vitro.
Budman DR; Calabro A; Kreis W
Anticancer Drugs; 2002 Nov; 13(10):1011-6. PubMed ID: 12439335
[TBL] [Abstract][Full Text] [Related]
35. Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitro.
Budman DR; Calabro A; Wang LG; Liu XM; Stiel L; Adams LM; Kreis W
Cancer Invest; 2000; 18(8):695-701. PubMed ID: 11107439
[TBL] [Abstract][Full Text] [Related]
36. Identification of unique synergistic drug combinations associated with downexpression of survivin in a preclinical breast cancer model system.
Budman DR; Calabro A; Rosen L; Lesser M
Anticancer Drugs; 2012 Mar; 23(3):272-9. PubMed ID: 23427335
[TBL] [Abstract][Full Text] [Related]
37. Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells.
Pichot CS; Hartig SM; Xia L; Arvanitis C; Monisvais D; Lee FY; Frost JA; Corey SJ
Br J Cancer; 2009 Jul; 101(1):38-47. PubMed ID: 19513066
[TBL] [Abstract][Full Text] [Related]
38. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
[TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells.
Niu J; Wang X; Qu J; Mager DE; Straubinger RM
BMC Cancer; 2020 Oct; 20(1):1024. PubMed ID: 33097020
[TBL] [Abstract][Full Text] [Related]
40. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
Foroodi F; Duivenvoorden WC; Singh G
Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]